| Schedule of Segment expenses reviewed by the CDMO |
The following table provides R&D expenses by program with a reconciliation to net income (loss) for the periods indicated, which are regularly reviewed by the CODM:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
|
(in thousands) |
|
|
(in thousands) |
|
Collaboration and other revenue |
$ |
6,500 |
|
|
$ |
— |
|
|
$ |
6,500 |
|
|
$ |
— |
|
Program expenses: |
|
|
|
|
|
|
|
|
|
|
|
BA3182 (CAB EpCAM x CAB CD3) |
$ |
322 |
|
|
$ |
2,136 |
|
|
$ |
2,141 |
|
|
$ |
3,076 |
|
Other CAB Programs |
|
2,031 |
|
|
|
8,032 |
|
|
|
2,044 |
|
|
|
14,300 |
|
Total program expenses |
|
2,353 |
|
|
|
10,168 |
|
|
|
4,185 |
|
|
|
17,376 |
|
Personnel and related |
|
481 |
|
|
|
2,145 |
|
|
|
2,248 |
|
|
|
5,603 |
|
Equity-based compensation |
|
135 |
|
|
|
567 |
|
|
|
457 |
|
|
|
1,342 |
|
Facilities and other |
|
373 |
|
|
|
804 |
|
|
|
1,034 |
|
|
|
1,718 |
|
Total research and development expenses |
|
3,342 |
|
|
|
13,684 |
|
|
|
7,924 |
|
|
|
26,039 |
|
General and administrative expenses |
|
|
|
|
|
|
|
|
|
|
|
Personnel and related |
|
727 |
|
|
|
1,577 |
|
|
|
1,910 |
|
|
|
3,680 |
|
Equity-based compensation |
|
485 |
|
|
|
810 |
|
|
|
1,119 |
|
|
|
1,680 |
|
Facilities and other |
|
1,719 |
|
|
|
2,576 |
|
|
|
4,628 |
|
|
|
4,862 |
|
Total general and administrative expenses |
|
2,931 |
|
|
|
4,963 |
|
|
|
7,657 |
|
|
|
10,222 |
|
Interest and other income (expense) |
|
225 |
|
|
|
(64 |
) |
|
|
3,189 |
|
|
|
2,216 |
|
Net income (loss) and comprehensive income (loss) |
$ |
452 |
|
|
$ |
(18,711 |
) |
|
$ |
(5,892 |
) |
|
$ |
(34,045 |
) |
|